KANDI GAMERDINGER: Open Payments
NPI 1841681608 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,614 in 127 payments from 11 companies in 2025. Trend: 2023 $3,010 · 2024 $3,146 · 2025 $2,614
Food & beverage: $2,614
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 58 | $1,171 |
| Gilead Sciences, Inc. | 33 | $748 |
| Antares Pharma, Inc. | 13 | $243 |
| Napo Pharmaceuticals Inc | 5 | $117 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| ABBVIE INC. | 3 | $57 |
| Abbott Laboratories | 3 | $52 |
| Verity Pharmaceuticals Inc. | 3 | $48 |
| TOLMAR, INC. | 3 | $43 |
| PFIZER INC. | 1 | $23 |
Products named: DOVATO, APRETUDE, CABENUVA, XYOSTED, Mytesi, PIFELTRO, Biktarvy, RUKOBIA.
Industry payments across AZ — which companies pay providers there.
